Bb5a31f81ClaimMeta's stock price declined by nearly 2% following the announcement of its $95 billion equity offering planAgreeDisagree
Bb5a31f81ClaimMeta announced a plan to raise up to $95 billion through successive stock sales to finance artificial intelligence infrastructureAgreeDisagree
Bb5a31f81ClaimAnthropic's losses exceeding $80 billion were driven primarily by an accounting adjustment related to financing agreementsAgreeDisagree
Bb5a31f81ClaimAnthropic recorded net losses exceeding $80 billion for the six months ending June 30thAgreeDisagree
Bb5a31f81ClaimAnthropic generated approximately $16 billion in revenue during the six-month period ending June 30thAgreeDisagree
Bb5a31f81ClaimAnthropic seeks to sell approximately $100 billion worth of shares in its initial public offeringAgreeDisagree
Bb5a31f81ClaimNvidia, AMD, and Broadcom expressed interest in purchasing portions of Meta's newly issued equityAgreeDisagree
Bb5a31f81ClaimAnthropic filed an S-1 registration statement with regulators to launch an initial public offeringAgreeDisagree
Bb5a31f81ClaimRisk factors constitute approximately one-quarter of Anthropic's 400-page S-1 filingAgreeDisagree
Bb5a31f81ClaimMeta's $95 billion financing plan comprises roughly $35 billion in public offerings alongside a newly created class of non-voting stockAgreeDisagree
Bb5a31f81ClaimMoonshot explicitly instructed social media influencers promoting Kimi K3.1 to omit paid partnership disclosure labels from their postsAgreeDisagree
Bb5a31f81ClaimOpenAI stated in a public security disclosure that additional software vulnerabilities would be revealedAgreeDisagree
Bb5a31f81ClaimPrior to Anthropic's prospectus release, certain investors targeted an IPO valuation of $2 trillion, while others sought $1.5 trillionAgreeDisagree
Bb5a31f81ClaimMoonshot released Kimi K3.1 Pro as the first model update to the Kimi K3 familyAgreeDisagree
Bb5a31f81ClaimMoonshot priced Kimi K3.1 at the same per-token rate as Sonnet 5.5 and GPT6 SOLAgreeDisagree
Bb5a31f81ClaimAnthropic released its initial public offering prospectus while targeting an IPO during the week of ThanksgivingAgreeDisagree
Bb5a31f81ClaimSince its founding, Leash Bio has screened approximately 1,000 proteins against chemical librariesAgreeDisagree
Bb5a31f81ClaimMoonshot priced Kimi K3.1 at approximately two-thirds the per-token cost of Kimi K3AgreeDisagree
Bb5a31f81ClaimLeash Bio produces two pre-measured protein-screening environments per dayAgreeDisagree